Cytomegalovirus (CMV) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (DNA Polymerase Inhibitors, Terminase Inhibitors, Antisense Oligonucleotides, Immunoglobulins, Virus-Specific T-cell Therapies), By Therapy Type (Prophylactic Therapy, Preemptive Therapy, Curative), By Application (Solid Organ Transplantation , Hematopoietic Stem Cell Transplantation , Congenital CMV Infection, HIV), By Route of Administration (Oral, Intravenous, Intramuscular), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies) Companies, and Country Forecast, 2021 to 2034
Global Cytomegalovirus (CMV) Therapeutics Market size is forecast to increase from $548.31 Million in 2026 to $893.91 Million in 2034 at a CAGR of 6.3% between 2026 and 2034.